<p>B cell deficient mice were vaccinated with Ad5-IiOva followed by a second vaccination with Ad5-IiGP or Ad5-IiNP on day 40. The group receiving Ad5-IiOva followed by Ad5-IiNP received a third vaccination with Ad5-IiGP 40 days after the second immunization. The GP- or Ad5-specific CD8 T cell response was measured on day 11 after the final vaccination (second or third). The experimental design and timeline is outlined above.</p
We evaluated changes in global and human immunodeficiency virus (HIV)–specific genital T cells after...
Adenoviral (Ad) vaccine vectors represent both a vehicle to present a novel antigen to the immune sy...
<div><p>The efficacies of many new T cell vaccines rely on generating large populations of long-live...
<p>Mice were initially vaccinated with either Ad5-IiOva followed by a second vaccination with Ad5-Ii...
<p><b>A.</b> Mice were vaccinated with Ad5-IiGP, followed by a second vaccination with the same vect...
<p>Mice were initially vaccinated with Ad5-IiOva followed by a second vaccination with Ad5-IiGP 40 d...
<div><p>Adenoviral vectors have shown a great potential for vaccine development due to their inheren...
<p>Mice were immunized twice with recombinant adenoviruses (group#1: Ad5-BTV-NS3 + Ad5-BTV-VP7 + Ad5...
<p>Groups of mice were either vaccinated with Ad5-IiOva or left untreated. Two months later, mice fr...
<p>Mice were initially vaccinated with Ad5-IiOva, followed by a second vaccination with Ad5-IiGP on ...
<p>Mice were vaccinated with Ad5-IiOva and 40 days later, serum (immune serum) was transferred to na...
<p><b>a</b>) CD8+ T cell responses obtained 14 days post vaccination against GP derived H-2<sup>d</s...
<p>Mice were vaccinated with Ad5-IiGP followed by a second vaccination with the same vector 40 days ...
<p>Groups of mice were vaccinated with the indicated vector doses and 14 days later the mice were sa...
<p>C57BL/6 mice were vaccinated with the adenoviral vaccines shown in the boxed insert and challenge...
We evaluated changes in global and human immunodeficiency virus (HIV)–specific genital T cells after...
Adenoviral (Ad) vaccine vectors represent both a vehicle to present a novel antigen to the immune sy...
<div><p>The efficacies of many new T cell vaccines rely on generating large populations of long-live...
<p>Mice were initially vaccinated with either Ad5-IiOva followed by a second vaccination with Ad5-Ii...
<p><b>A.</b> Mice were vaccinated with Ad5-IiGP, followed by a second vaccination with the same vect...
<p>Mice were initially vaccinated with Ad5-IiOva followed by a second vaccination with Ad5-IiGP 40 d...
<div><p>Adenoviral vectors have shown a great potential for vaccine development due to their inheren...
<p>Mice were immunized twice with recombinant adenoviruses (group#1: Ad5-BTV-NS3 + Ad5-BTV-VP7 + Ad5...
<p>Groups of mice were either vaccinated with Ad5-IiOva or left untreated. Two months later, mice fr...
<p>Mice were initially vaccinated with Ad5-IiOva, followed by a second vaccination with Ad5-IiGP on ...
<p>Mice were vaccinated with Ad5-IiOva and 40 days later, serum (immune serum) was transferred to na...
<p><b>a</b>) CD8+ T cell responses obtained 14 days post vaccination against GP derived H-2<sup>d</s...
<p>Mice were vaccinated with Ad5-IiGP followed by a second vaccination with the same vector 40 days ...
<p>Groups of mice were vaccinated with the indicated vector doses and 14 days later the mice were sa...
<p>C57BL/6 mice were vaccinated with the adenoviral vaccines shown in the boxed insert and challenge...
We evaluated changes in global and human immunodeficiency virus (HIV)–specific genital T cells after...
Adenoviral (Ad) vaccine vectors represent both a vehicle to present a novel antigen to the immune sy...
<div><p>The efficacies of many new T cell vaccines rely on generating large populations of long-live...